The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced unresectable mesothelioma from the JAVELIN solid tumor phase Ib trial: Safety, clinical activity, and PD-L1 expression.
 
Raffit Hassan
Research Funding - Aduro Biotech (Inst); Bayer (Inst); Morphotek (Inst); Roche TCRC (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for MPF assay from Morphotek (approximately $700/year)
 
Anish Thomas
No Relationships to Disclose
 
Manish R. Patel
No Relationships to Disclose
 
John J. Nemunaitis
No Relationships to Disclose
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
John D. Powderly
Employment - BioCytics; Human Appications Lab
Stock and Other Ownership Interests - BioCytics
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amplimmune; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Amplimmune; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; ImClone Systems; Incyte; Lilly; Macrogenics
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Afshin Dowlati
Consulting or Advisory Role - Boehringer Ingelheim; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Lilly/ImClone (Inst); MedImmune (Inst); OncoMed (Inst)
 
Franklin Chen
Speakers' Bureau - Celgene; Onyx
 
Joseph Leach
Employment - Minnesota Oncology
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Genentech (Inst)
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis; Pfizer
 
Claire F. Verschraegen
No Relationships to Disclose
 
Jean-Pierre Delord
No Relationships to Disclose
 
Hans Juergen Grote
Employment - Merck
 
Anja von Heydebreck
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology